oral semaglutide novo nordisk says works in diabetic kids Here's Novo Nordisk's First Oral Hims & Hers makes deal

B.MacConellL.SarinV.TrautmannM.HerbertP

Physical Activity: Moving Towards Better Health The misconception that medication eliminates the need for exercise is a common pitfall

While GLP-1 initiation reduces spending on other diabetes medications by $189 annually, this offset is insufficient to counterbalance increased outpatient costs

People fail to recognize these are two completely different classes of peptides working through entirely different biological pathways, and that using them together is superior to using either one alone

In the meantime, perpetuating the idea that anyone trying to live longer should try GLP-1s can actually be dangerous